Surprisingly, while U2AF1 mutations have been observed in ~3% of lung adenocarcinomas (LUAD), their frequency in other lung cancer subtypes appears to be lower, including in squamous cell carcinomas (LUSC)34,35 and small cell carcinomas (SCLC)36. This evidence concerns the gene U2AF1 and lung carcinoma.